Back to results
US 2008/0292602 A1Published application
T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
AssigneeMediGene AG
InventorsBent Karsten Jakobsen, Ll Yi
Life of this patent
Estimating the term…
Abstract
The present invention provides isolated T cell receptors (TCRs) having the property of specifically binding to the VYGFVRACL-HLA-A24 peptide-MHC. Such TCRs are useful, either alone or associated with a therapeutic agent, for targeting cancerous cells presenting the complex.
Claims26
An isolated T cell receptor (TCR) having the property of specifically binding to VYGFVRACL-HLA-A24.
7-9. (canceled)
20-22. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.